06/11/2025
11:15 PM | IO Biotech (Filer)
| Form EFFECT | |
06/06/2025
3:25 PM | Elling Christian E (Reporting)
IO Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
3:26 PM | Glaub Kathleen Sereda (Reporting)
IO Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
3:26 PM | Hirth Peter (Reporting)
IO Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
3:27 PM | Hunter Heidi (Reporting)
IO Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
3:27 PM | IO Biotech (Issuer)
Smith David V (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2025
7:33 AM | IO Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/02/2025
6:53 AM | Hunter Heidi (Reporting)
IO Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2025
3:05 PM | IO Biotech (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
05/14/2025
7:54 AM | IO Biotech (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/14/2025
7:06 AM | IO Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for IOBT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for IO Biotech and its competitors with MarketBeat's FREE daily newsletter. |
04/30/2025
3:43 PM | IO Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/04/2025
3:16 PM | IO Biotech (Issuer)
Sullivan Amy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2025
3:18 PM | IO Biotech (Issuer)
Zocca Mai-Britt (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2025
3:12 PM | Burkavage Brian (Reporting)
IO Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2025
3:13 PM | IO Biotech (Issuer)
Smith Devin Whittemore (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
3:47 PM | IO Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
4:54 PM | IO Biotech (Subject)
Samsara BioCapital, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
02/13/2025
3:15 PM | HBM Healthcare Investments Ltd. (0001232258) (Filed by)
IO Biotech (Subject)
| Form SCHEDULE 13G/A | |
12/27/2024
3:16 PM | IO Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/26/2024
7:50 AM | Ahmad Qasim Iftikhar (Reporting)
IO Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
5:56 PM | IO Biotech (Issuer)
Zocca Mai-Britt (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
5:53 PM | IO Biotech (Issuer)
Sullivan Amy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
5:52 PM | IO Biotech (Issuer)
Smith Devin Whittemore (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
7:10 AM | IO Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/16/2024
5:06 AM | IO Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
4:30 PM | IO Biotech (Subject)
Stonepine Capital Management, LLC (Filed by)
| Form SC 13G/A | |
11/12/2024
6:11 AM | IO Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/17/2024
8:01 PM | IO Biotech (Subject)
Novo Holdings A/S (Filed by)
| Form SC 13D/A | |
09/11/2024
8:04 PM | IO Biotech (Subject)
Novo Holdings A/S (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/30/2024
3:10 PM | IO Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
6:05 AM | IO Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/26/2024
8:22 PM | IO Biotech (Issuer)
Novo Holdings A/S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/25/2024
8:38 PM | IO Biotech (Subject)
Novo Holdings A/S (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
